Coronavirus News LIVE Updates: As Covid-19 continues to recede across the country, there is a North-South divide in the failing cases. The North Indian states are witnessing a steady decline in compared to Maharashtra and Southern States. The highest downfall of seven day rolling average of daily cases in Haryana has declined at an average rate of 8.9 percent each day. The decline has been high in Rajasthan (8.5%), Delhi (8.2%), Bihar (8.1%), UP (7.8%) and Uttarakhand (7.6%).
Whereas in other South Indian, the decline in cases was more gradual ranging from 2.7% in Tamil Nadu to 4.2% in Andhra Pradesh. The difference between the rates of decline in the north and south India is too stark for it to be just a statistical quirk, a report in The Times of India said. However, experts say that the stark difference is due to leakier Covid reporting system in North India might be behind the reason for divide.
The All India Institute of Medical Sciences (AIIMS) in Delhi plans to begin clinical trials of Bharat Biotech's Covid-19 vaccine "Covaxin” on children, ANI cited sources as saying. AIIMS Patna has been already been conducting a Paediatric clinical trial of Covaxin after Bharat Biotech gained approval from the Drugs Controller General of India (DCGI) to begin paediatric clinical studies on May 11. At AIIMS Patna, trials for children aged 12 to 18 have begun. Following this, trials will be conducted for the age groups of 6-12 years and 2-6 years, Dr Prabhat Kumar Singh, Director, AIIMS, Patna, told the news agency. Earlier, VK Paul, Member (Health), Niti Aayog had said, "Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years.”
Delhi recorded the lowest positivity rate at 0.5 percent as the national capital reported 381 new instances of the COVID-19 infection, the lowest since March 15. Also, 34 more people have succumbed to the disease in a day, the lowest in around two months. These new fatalities pushed the death toll here to 24,591.